Skip to content

Neuromuscular Strength Factors Influencing Vertical Jump Performance

The Relationship Between Lower-Limb Muscle Strength and Related Parameters With Vertical Jump in Young Adult Males

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07560930
Enrollment
81
Registered
2026-05-01
Start date
2024-03-01
Completion date
2025-12-12
Last updated
2026-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Conditions or Focus of Study

Keywords

Muscle Strength, Athletic Performance, Physical Performance

Brief summary

This cross-sectional observational study is designed to comprehensively analyze the relationship between high-volume isokinetic muscle performance and explosive vertical jump capacity in healthy, recreationally active young adult males. While traditional neuromuscular assessments frequently emphasize momentary peak force (Peak Torque), this study investigates the hypothesis that sustained mechanical work capacity (Total Work) and fatigue resistance (Fatigue Index) are more robust predictors of complex explosive tasks such as the countermovement jump (CMJ). Methodology and Testing Protocol: Participants will complete all assessments in a single laboratory session under controlled environmental conditions. The standardized testing sequence is as follows: 1. Anthropometric and Body Composition Assessment: Participants' height, body mass, and body fat percentage will be measured using a multi-frequency bioelectrical impedance analyzer (InBody 270) following standard manufacturer protocols. 2. Countermovement Jump (CMJ) Test: Following a standardized dynamic warm-up, participants will perform the CMJ test on a validated contact mat system (SmartJump). Participants will start from a standing position with hands placed on the hips to eliminate the influence of arm swing. They will perform a quick downward countermovement to approximately 90 degrees of knee flexion and execute a maximal vertical jump. Three trials will be conducted with a 30-second rest interval between attempts, and the highest jump will be recorded for analysis. 3. Isokinetic Muscle Strength and Fatigue Test: After a 5-minute cycle ergometer warm-up, participants will undergo isokinetic testing on a computerized dynamometer (Humac Norm). Following familiarization trials, participants will execute a high-volume fatigue protocol consisting of 50 continuous, maximal concentric knee flexion and extension repetitions at an angular velocity of 180°/sec for both legs. Primary Variables Analyzed: From the isokinetic protocol, the primary variables of interest include Peak Torque (Nm), Average Power (W), Total Work (Nm), and the Isokinetic Fatigue Index (%). These mechanical metrics will be statistically analyzed against the maximum CMJ height (cm) to evaluate the predictive strength of sustained mechanical work capacity versus momentary force production on explosive motor performance.

Interventions

None listed

Sponsors

Uludag University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
MALE
Age
22 Years to 26 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy young adult males * Moderately or highly physically active (e.g., walking or jogging 1-2 times weekly) * No consumption of any ergogenic aids or stimulants in the past 6 months

Exclusion criteria

* Presence of any musculoskeletal pain * History of major lower body surgery within the last six months

Design outcomes

Primary

MeasureTime frameDescription
Isokinetic Extension Total Work (ETW)Baseline (Single laboratory visit)The total mechanical work capacity of the knee extensor muscles, measured in Newton-meters (Nm) over a 50-repetition maximal isokinetic protocol at 180°/sec.
Countermovement Jump (CMJ) HeightBaseline (Single laboratory visit)Maximum vertical jump height achieved during the CMJ test, measured in centimeters (cm) using a contact mat system.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 2, 2026